What is the recommended treatment regimen and dosing for typhoid fever in a healthy adult?

Typhoid Fever Treatment and Dosing

For fully susceptible typhoid fever in healthy adults, use fluoroquinolones (ciprofloxacin 500 mg twice daily for 7 days, or gatifloxacin 10 mg/kg once daily for 7 days, or ofloxacin); for quinolone-resistant strains, use azithromycin 20 mg/kg once daily for 7 days or ceftriaxone 3-4 g IV once daily for 3-7 days. 1

Treatment Selection Based on Resistance Pattern

Fully Susceptible Strains (First-Line)

• Fluoroquinolones are the WHO-recommended first-line oral therapy for fully susceptible Salmonella Typhi strains 1
• Ciprofloxacin 500 mg orally twice daily for 7 days achieves 96% cure rates with rapid defervescence (median 4 days) 2
• Gatifloxacin 10 mg/kg once daily for 7 days demonstrates equivalent efficacy to azithromycin with median fever clearance of 106 hours 3
• Ofloxacin achieves 100% cure rates without relapse when used appropriately 4

Alternative Agents for Susceptible Strains

• Chloramphenicol, amoxicillin, or trimethoprim-sulfamethoxazole serve as WHO-recommended alternatives when fluoroquinolones cannot be used 1
• These older agents may be reconsidered in areas where susceptibility has re-emerged 5

Quinolone-Resistant Strains (Increasingly Common)

Critical consideration: Nalidixic acid resistance serves as a marker for fluoroquinolone resistance—96% of isolates in recent studies showed this pattern, particularly from South Asia 3, 5

Preferred Options:

• Azithromycin 20 mg/kg once daily for 7 days is highly effective with lower treatment failure rates (OR 0.48,95% CI 0.26-0.89) compared to fluoroquinolones 1
• Azithromycin demonstrates substantially lower relapse rates than ceftriaxone (OR 0.09,95% CI 0.01-0.70) 1
• Ceftriaxone 3-4 g IV once daily is the alternative parenteral option 1

Ceftriaxone Dosing Regimens

Short-Course Therapy (Uncomplicated Cases)

• 3-4 g IV once daily for 3 days achieves 95-100% cure rates in uncomplicated typhoid fever 6, 7
• The 3-day regimen is adequate and does not increase relapse risk compared to longer courses 7

Standard Course

• Ceftriaxone 3-4 g IV once daily for 7 days when treating quinolone-resistant strains 5
• Higher doses (≥3 g once daily) or longer duration are needed to reduce relapse incidence 4

Comparative Performance

• Ceftriaxone may result in decreased clinical failure compared to azithromycin (RR 0.42,95% CI 0.11-1.57), though evidence certainty is low 5
• Time to defervescence with ceftriaxone is 0.52 days shorter than azithromycin (95% CI -0.91 to -0.12) 5

Critical Resistance Considerations

Extensively Drug-Resistant (XDR) Typhoid

• XDR strains from Pakistan (ongoing outbreak since 2016) respond to only limited antibiotics 8, 9
• Azithromycin resistance is emerging, compounding treatment challenges 8
• Third-generation cephalosporin resistance is spreading, limiting ceftriaxone utility in some regions 8

Geographic Patterns

• Fluoroquinolone resistance in South Asia often precludes ciprofloxacin use 5
• Multidrug resistance affects 58% of isolates in recent Vietnamese studies 3
• Local resistance patterns must guide antibiotic selection 5, 9

Common Pitfalls to Avoid

• Do not use cefixime as first-line therapy—it shows increased clinical failure (RR 13.39), microbiological failure (RR 4.07), and relapse (RR 4.45) compared to fluoroquinolones 5
• Avoid fluoroquinolones empirically in patients returning from South Asia without susceptibility data due to high nalidixic acid resistance rates 3, 5
• Do not underdose ceftriaxone—use at least 3 g once daily to prevent relapse 4
• Hospital stay may be longer with ceftriaxone (mean 12 days) versus fluoroquinolones (mean 9 days) when both are effective 5

Cost-Effectiveness Note

Gatifloxacin costs approximately one-third the price of azithromycin in endemic settings, making it highly cost-effective for susceptible strains 3